Sort   by:  
 Page size 
TranscriptomicsTLR2/6 agonists and IFNgamma induce CXCL10 from melanoma
Clinical approaches to treat advanced melanoma include immune therapies, whose benefits depend on tumor-reactive T-cells to infiltrate metastases. However, most tumors lack significant immune infiltration prior to therapy, and some immune therapies are hindered by a persistent lack of immune cell in...
ORGANISM(S): Homo sapiens 
2015-11-22 | E-GEOD-64506 | biostudies-arrayexpress
GenomicsAnalysis of the IFNgamma induced pathways in murine macrophages
Analysis of the IFNgamma induced pathways in murine macrophages
PRJNA478256 | ENA
UnknownNeutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice.
Not available
S-EPMC3378118 | biostudies-literature
TranscriptomicsTLR2/6 agonists and IFNgamma induce CXCL10 from melanoma
Clinical approaches to treat advanced melanoma include immune therapies, whose benefits depend on tumor-reactive T-cells to infiltrate metastases. However, most tumors lack significant immune infiltration prior to therapy, and some immune therapies are hindered by a persistent lack of immune cell in...
ORGANISM(S): Homo sapiens 
2015-11-22 | GSE64506 | GEO
UnknownIFNgamma-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice.
Not available
S-EPMC2118311 | biostudies-literature
TranscriptomicsTranscription profiling of mouse CMS4 and CMS4-met cell lines after IFNgamma treatment
The CMS4 sarcoma, kindly provided by A. DeLeo (University of Pittsburgh, Pittsburgh, PA), is a solid tumor of BALB/c (H-2d) origin, which grows aggressively in naive, syngeneic hosts following a s.c. transplant. Although the parental tumor cell line forms few metastatic foci in the lungs following i...
ORGANISM(S): Mus musculus 
2005-05-08 | E-MEXP-288 | biostudies-arrayexpress
TranscriptomicsImmunologic Effects of a Peptide Vaccine with Intralesional IFNgamma For Treatment of Melanoma
Introduction: Optimal approaches to induce T-cell infiltration of tumors are not known. Chemokines CXCL9, CXCL10, and CXCL11 support effector T-cell recruitment, and may be induced by IFNgamma. This study tests the hypothesis that intratumoral administration of IFNgamma will induce CXCL9-11, and wil...
ORGANISM(S): Homo sapiens 
2017-03-01 | GSE79741 | GEO
TranscriptomicsHela cells treated with or without IFNgamma at different time points
The purpose of this study is to define which genes are IFNgamma sensitive, resistant, or irrelevant in our desired 16MB Human genome. Different ISGs(Interferon sensitive genes) were categorized based on this expression array data and can be visulized in our 16MB IFNgamma genes DB. Keywords: treated/...
ORGANISM(S): Homo sapiens 
2009-01-15 | GSE11299 | GEO
TranscriptomicsWhole-genome expression analysis in IFNgamma stimulated bone marrow-derived macrophages from transgenic mice expressing only non-nuclear mutant Socs1
To study the role of SOCS1 in the cell nucleus in vivo, we generated a transgenic mouse model using a bacterial artificial chromosome (BAC) containing a mutated Socs1 locus (non-nuclear Socs1ΔNLS), GFP and firefly Luciferase, termed MGL. MGL transgenic mice expressing only non-nuclear mutant Socs1 ...
ORGANISM(S): Mus musculus 
2016-11-10 | E-MTAB-4938 | biostudies-arrayexpress
TranscriptomicsIFNgamma and 1a,25(OH)2D3 dependent gene expression in bone marrow derived macrophages
Gene expression profiling of macrophages derived from WT and Vdr deficient mice after stimulation with IFNgamma and/or 1alpha,25(OH)2D3 Keywords = macrophages Keywords = VDR Keywords = activated vitamin D3 Keywords = IFNgamma Keywords = KO mice Keywords: dose response
ORGANISM(S): Mus musculus 
2005-04-21 | GSE2421 | GEO
Sort   by:  
 Page size